BHARAT BIJLEE LTD.-$ - 503960 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Postal Ballot Notice - Newspaper Publication23-01-2024
23-01-2024
BHARAT BIJLEE LTD.-$ - 503960 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Poistal Ballot Notice22-01-2024
BHARAT BIJLEE LTD.-$ - 503960 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication - Financial Results15-01-2024
BHARAT BIJLEE LTD.-$ - 503960 - Results-Financial Results For The Quarter And Nine Months Ended Decemer 31, 2023.
Statement of Unaudited Financial Results of the Company, for the quarter and nine months ended December 31, 202312-01-2024
BHARAT BIJLEE LTD.-$ - 503960 - Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday, January 12, 2024
Outcome of the Board Meeting held on Friday, January 12, 202412-01-2024
BHARAT BIJLEE LTD.-$ - 503960 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018, for the quarter ended December 31, 2023.09-01-2024
BHARAT BIJLEE LTD.-$ - 503960 - Board Meeting Intimation for The Adoption Of The Unaudited Financial Results Of The Company, For The Quarter And Nine Months Ended December 31, 2023.
BHARAT BIJLEE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/01/2024 ,inter alia, to consider and approve the Unaudited Financial Results of the Company, for the quarter and nine months ended December 31, 2023.26-12-2023
BHARAT BIJLEE LTD.-$ - 503960 - Closure of Trading Window
NOTICE FOR CLOSURE OF TRADING WINDOW26-12-2023
Biocon Biologics partners with Sandoz to distribute Adalimumab BS Subcutaneous injection in Japan
BBL has acquired the global biosimilars portfolio of Viatris, including Adalimumab Fujifilm Kyowa Kirin Biologics Co. Ltd23-12-2023
BHARAT BIJLEE LTD.-$ - 503960 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication - Unaudited Financial Results of the Company, for the quarter and half year ended September 30, 2023.01-11-2023